For the Quarter Ending March 2026
Salcaprozate Sodium Prices in North America
- In United States, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q1 2026, driven by surging costs.
- March 2026 producer prices increased 4.0% year-over-year, forcing manufacturers to pass costs to Salcaprozate Sodium buyers.
- March 2026 consumer inflation rose 3.3% year-over-year, increasing logistics costs for the Salcaprozate Sodium supply chain.
- Retail sales grew 4.0% year-over-year in March 2026, supporting pharmaceutical demand for Salcaprozate Sodium formulations.
- March 2026 unemployment at 4.3% sustained insurance coverage, bolstering Salcaprozate Sodium demand for expensive prescription medications.
- March 2026 industrial production grew 0.7% year-over-year, reflecting stable manufacturing conditions for Salcaprozate Sodium chemical synthesis.
- The Salcaprozate Sodium Demand Outlook strengthened in January 2026 following a major FDA oral drug approval.
- The Salcaprozate Sodium Production Cost Trend surged in early March 2026 as regional phenol supplies tightened.
- The Salcaprozate Sodium Price Forecast indicated an upward trend in Q1 2026 amid expanding manufacturing index.
Why did the price of Salcaprozate Sodium change in March 2026 in North America?
- Phenol feedstock costs surged in early March 2026 due to upstream shortages and energy costs.
- Salcaprozate Sodium demand strengthened in January 2026 following a major FDA oral macromolecule drug approval.
- Producer prices rose 4.0% year-over-year in March 2026, forcing manufacturers to pass on elevated costs.
Salcaprozate Sodium Prices in APAC
- In China, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q1 2026, tracking escalating costs.
- The Salcaprozate Sodium Production Cost Trend rose in March 2026 as Producer Price Index increased 0.5%.
- The Salcaprozate Sodium Demand Outlook stabilized in March 2026, supported by 1.0% Consumer Price Index growth.
- Industrial production grew 5.7% and the Manufacturing Index expanded in March 2026, supporting pharmaceutical formulation.
- Retail sales grew 1.7% in March 2026, reflecting softer consumer spending for premium oral medications.
- The unemployment rate reached 5.4% in March 2026, straining household incomes for discretionary healthcare purchases.
- Consumer confidence hit 91.6 in February 2026, prompting cautious household spending on premium lifestyle drugs.
- The Salcaprozate Sodium Price Forecast showed upward pressure in March 2026 due to surging benzene costs.
Why did the price of Salcaprozate Sodium change in March 2026 in APAC?
- Upstream benzene and phenol feedstock costs surged significantly in China from February to March 2026.
- Import volumes of upstream benzene into China contracted sharply in March 2026 amid shipping disruptions.
- Global crude oil benchmarks surged and regional precursor phenol inventories tightened consistently throughout Q1 2026.
Salcaprozate Sodium Prices in Europe
- In Germany, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q1 2026, driven by surging energy costs.
- In March 2026, consumer inflation hit 2.7%, while producer prices fell 0.2%, reflecting mixed upstream cost pressures.
- The Manufacturing Index expanded in March 2026, despite stagnant industrial production at 0.0% during February 2026.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, supporting pharmaceutical purchasing power.
- Consumer confidence dropped to -24.7 in March 2026, negatively impacting the Salcaprozate Sodium Demand Outlook.
- Demand for Salcaprozate Sodium precursors benzene and phenol deteriorated significantly during March 2026 across the region.
- The Salcaprozate Sodium Production Cost Trend increased as propylene and Brent crude oil prices surged in March 2026.
- European import availability tightened in March 2026 due to Middle East disruptions and Strait of Hormuz closures.
- Regional chemical manufacturing production capacity contracted structurally in February 2026 due to widespread industry facility closures.
Why did the price of Salcaprozate Sodium change in March 2026 in Europe?
- The Salcaprozate Sodium Price Forecast trended upward as energy and petrochemical feedstock costs strengthened in March 2026.
- Severe supply disruptions and logistical constraints in the Middle East restricted key precursor imports in March 2026.
- Higher consumer inflation at 2.7% in March 2026 increased operational and utility costs for fine chemical synthesis.
For the Quarter Ending December 2025
Salcaprozate Sodium Prices in North America
- In the United States, the Salcaprozate Sodium Price Index rose in Q4 2025, driven by increasing costs and robust pharmaceutical demand.
- Production costs increased due to a 3.0% PPI rise in November 2025, reflecting higher input expenses.
- Demand was supported by a 2.0% industrial production increase in December 2025, indicating expanding manufacturing.
- The US pharmaceutical market expanded in 2025, positively influencing Salcaprozate Sodium demand outlook.
- Consumer spending, boosted by a 3.3% retail sales increase in November 2025, supported pharmaceutical product demand.
- US manufacturing inventories contracted in October 2025, as chemical companies aimed to draw down stock.
- Trade and tariff volatility injected unpredictability into the chemical market during Q4 2025.
- Elevated cost of goods for chemical producers persisted in 2025, impacting overall profitability.
- A 2.7% CPI increase in December 2025 indicated general inflation, raising operational expenses.
Why did the price of Salcaprozate Sodium change in December 2025 in North America?
- Rising input costs, evidenced by a 3.0% PPI increase in November 2025, pressured Salcaprozate Sodium production.
- Expanding US pharmaceutical market in 2025 provided underlying support for Salcaprozate Sodium demand.
- Contracting US chemicals output in October 2025 influenced overall supply dynamics and market balance.
Salcaprozate Sodium Prices in APAC
- In China, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q4 2025, influenced by accelerating input costs.
- Salcaprozate Sodium production costs increased in December 2025 due to higher raw material prices and rising industrial power rates.
- Demand for Salcaprozate Sodium improved in December 2025, supported by an expanding Manufacturing Index.
- China's industrial production grew by 5.2% year-on-year in December 2025, driving demand for chemical intermediates.
- Raw materials inventory in China's manufacturing industry remained below the threshold in December 2025.
- Consumer Price Index (CPI) rose 0.8% year-on-year in December 2025, reflecting subdued consumer demand.
- Producer Price Index (PPI) declined 1.9% year-on-year in December 2025, indicating falling producer-level prices.
- Retail sales grew 0.9% and unemployment was 5.1% in December 2025, reflecting cautious economic conditions.
- The price of Salcaprozate Sodium in Q4 2025 setteled at USD 1059 /MT in Asia.
Why did the price of Salcaprozate Sodium change in December 2025 in APAC?
- Input cost inflation for manufacturing accelerated in December 2025 due to higher raw material prices.
- China's Manufacturing Index moved into the expansionary range in December 2025, boosting demand.
- Industrial production grew 5.2% year-on-year in December 2025, increasing demand for chemical inputs.
Salcaprozate Sodium Prices in Europe
- In Germany, Salcaprozate Sodium prices faced downward pressure in Q4 2025, as producer prices declined by 2.5% year-on-year in December 2025.
- Salcaprozate Sodium production costs remained elevated in Q4 2025 due to uncompetitive energy and raw material expenses.
- Demand for Salcaprozate Sodium was supported by robust growth in the German pharmaceutical sector in 2025.
- The Salcaprozate Sodium price outlook for early 2026 remained uncertain amidst volatile natural gas prices.
- Overall chemical demand in Germany remained subdued in Q4 2025, despite a 1.1% rise in retail sales in November 2025.
- German industrial production increased by 0.8% year-on-year in October 2025, supporting supply chains.
- The Manufacturing Index was contracting in December 2025, reflecting a slowdown in German industrial activity.
- General inflation, indicated by a 1.8% CPI rise year-on-year in December 2025, increased operational costs.
- Consumer confidence was significantly pessimistic at -17.5 in December 2025, alongside a 6.2% unemployment rate.
Why did the price of Salcaprozate Sodium change in December 2025 in Europe?
- Producer prices in Germany declined by 2.5% year-on-year in December 2025.
- Overall chemical demand remained subdued in Q4 2025, despite a 1.1% rise in retail sales.
- Consumer confidence was significantly pessimistic at -17.5 in December 2025.
For the Quarter Ending September 2025
APAC
- In China, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q3 2025, driven by firming feedstock costs.
- Salcaprozate Sodium production costs increased in Q3 2025 due to tightened salicylic acid supply from environmental inspections.
- Demand for Salcaprozate Sodium strengthened in Q3 2025, supported by robust pharmaceutical market growth and accelerating clinical trials.
- China's industrial production grew by 6.5% in September 2025, indicating sustained demand for chemical inputs.
- Retail sales increased by 3.0% in September 2025, bolstering consumer spending on healthcare products.
- The Manufacturing Index was contracting in September 2025, suggesting some slowdown in overall industrial activity.
- Deflationary CPI at -0.3% and PPI at -2.3% in September 2025 exerted downward pressure on end-product pricing.
- Salcaprozate Sodium's price forecast suggests continued upward pressure from feedstock costs and robust pharmaceutical demand.
Why did the price of Salcaprozate Sodium change in September 2025 in APAC?
- Salicylic acid feedstock costs firmed in Q3 2025, and supply tightened due to environmental inspections in China.
- Robust pharmaceutical market growth and accelerating clinical trials in China boosted Salcaprozate Sodium demand.
- Industrial production increased by 6.5% in September 2025, supporting demand despite a contracting Manufacturing Index.
Europe
- In Germany, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q3 2025, driven by strengthening pharmaceutical demand.
- Production costs for Salcaprozate Sodium rose from elevated natural gas and industrial electricity prices in Q3 2025.
- Demand for Salcaprozate Sodium strengthened in Q3 2025, supported by sustained growth in oral pharmaceutical formulations.
- Germany's Manufacturing Index contracted in Q3 2025, indicating a slowdown in overall industrial activity.
- Industrial production declined by 1.0% in September 2025, reflecting weaker demand from key industrial consumers.
- Producer prices for industrial products decreased by 1.7% in September 2025, primarily due to lower energy prices.
- The Consumer Price Index increased by 2.4% in September 2025, suggesting rising overall production costs for manufacturers.
- Stable retail sales (0.2% in September 2025) and unemployment (6.3%) provided a neutral backdrop for consumer spending.
- Factors influencing Salcaprozate Sodium price outlook include robust pharmaceutical demand and persistent high energy costs.
Why did the price of Salcaprozate Sodium change in September 2025 in Europe?
- Strengthening German pharmaceutical demand (sector signal) supported Salcaprozate Sodium prices.
- Elevated natural gas and industrial electricity prices increased production costs.
- Overall industrial production declined 1.0% in September 2025, moderating demand for chemical inputs.
North America
- In United States, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
- Salcaprozate Sodium production costs faced upward pressure from a 2.6% year-over-year Producer Price Index increase in August 2025.
- Overall inflation, with Consumer Price Index up 3.0% year-over-year in September 2025, raised raw material and labor expenses.
- Salcaprozate Sodium demand outlook was supported by strengthened pharmaceutical sector activity in Q3 2025.
- Rising US natural gas prices and wholesale electricity costs in Q3 2025 increased energy inputs for production.
- North American caustic soda feedstock costs experienced a quarterly decrease during Q3 2025, partially mitigating overall cost trends.
- A low 0.1% year-over-year industrial production growth in September 2025 indicated sluggish broader manufacturing activity.
- Strong retail sales, up 5.42% year-over-year in September 2025, indirectly bolstered pharmaceutical product demand.
Why did the price of Salcaprozate Sodium change in September 2025 in North America?
- Increased production costs, driven by a 2.6% year-over-year Producer Price Index rise in August 2025, impacted Salcaprozate Sodium.
- Strengthened pharmaceutical sector demand in Q3 2025, with increased regulatory approvals, supported Salcaprozate Sodium prices.
- Rising US natural gas prices and wholesale electricity costs in Q3 2025 contributed to higher manufacturing expenses.
